Table 1

Natural history parameters for HIV infection receiving first-line treatment (Source: ATHENA cohort data17) Refer to the technical appendix for details

ParameterValueUnit
Log10 viral load at treatment initiation (normal distribution)Mean5.1Log copies per microlitre
Variance0.40
Fraction achieving suppression*0.70Fraction
Fraction with good adherence0.94Fraction
Waiting time until viral suppression, if suppression and good adherence (exponential distribution)Median5.38Months
Waiting time until viral suppression, if suppression and not good adherence (exponential distribution)Median5.92Months
Waiting time (months) until viral rebound, if good adherence (double Weibull distribution), assuming shortened (s) survival times (used unless otherwise stated) or extended (e) survival.Shape11.14 (e) 10.23 (s)Months
Scale1456.65 (e) 153.25 (s)
Shape21.92 (e) 1.25 (s)
Scale220.70 (e) 41.58 (s)
Weighting0.91 (e) 0.77 (s)
Waiting time until viral rebound, if not good adherence (Weibull distribution)Shape11.14Months
Scale1132.86
Rate of increase in log10 viral load on rebound, if good adherenceRate0.07 (se=0.002)Log10 copies per microlitre per month
Rate of increase in log10 viral load on rebound, if not good adherenceRate0.16 (se=0.01)Log10 copies per microlitre per month
Maximum survival time with non-suppressed viral loadMax1Years
Log10 viral load if no suppression (normal distribution)Mean3.80Log copies per microlitre
Variance0.84
  • * Suppression is defined as at least two consecutive viral load measurements <500 HIV RNA copies per millilitre.

  • Adherence is classified as good or poor based on the measurement of plasma drug levels.

  • At all times in the simulation, viral load is limited to less than or equal to the 95th centile of viral loads at treatment initiation in the ATHENA data (equal to six log-copies).